Wegovy weight loss sustained for four years in trial, Novo Nordisk says - Reuters
- Wegovy weight loss sustained for four years in trial, Novo Nordisk says Reuters
- What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and heart protection CNN
- Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study Finds Forbes
- Weight loss drug could reduce heart attack risk by 20%, study finds The Guardian
- Obesity drug cuts risk of heart attack or stroke regardless of weight lost, study finds Sky News